Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosome

Journal of Virological Methods

Volumn 168, Issue 1-2, 2010, Pages 233-236

  Cottingham, Matthew G ^a   Gilbert, Sarah C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bacterial artificial chromosome; Modified vaccinia virus Ankara; Poxvirus; Recombineering; Vaccine; Vaccinia; Vector

Indexed keywords

GENOMIC DNA; RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CONTROLLED STUDY; DNA SEQUENCE; GENE CASSETTE; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENETIC ENGINEERING; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; VACCINIA VIRUS; VIRUS GENOME; VIRUS ISOLATION; VIRUS RECOMBINATION; BACTERIA; GENE VECTOR; GENETIC RECOMBINATION; GENETICS; HUMAN; PROCEDURES;

BACTERIA (MICROORGANISMS); BRYOPHYTA; POXVIRIDAE; VACCINIA VIRUS; VACCINIA VIRUS ANKARA;

BACTERIA; CHROMOSOMES, ARTIFICIAL, BACTERIAL; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; RECOMBINATION, GENETIC; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL VACCINES;

EID: 77955095684     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.04.012     Document Type: Article

References (13)

1. Cottingham M.G., Andersen R.F., Spencer A.J., Saurya S., Furze J., Hill A.V., Gilbert S.C. Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA). PLoS ONE 2008, 3:e1638.
2. Di Lullo G., Soprana E., Panigada M., Palini A., Agresti A., Comunian C., Milani A., Capua I., Erfle V., Siccardi A.G. The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use. J. Virol. Methods 2009, 163:195-204.
3. Domi A., Moss B. Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells. Proc. Natl. Acad. Sci. USA 2002, 99:12415-12420.
4. Drexler I., Staib C., Sutter G. Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?. Curr. Opin. Biotechnol. 2004, 15:506-512.
5. Falkner F.G., Moss B. Transient dominant selection of recombinant vaccinia viruses. J. Virol. 1990, 64:3108-3111.
6. Gomez C.E., Najera J.L., Krupa M., Esteban M. The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer. Curr. Gene Ther. 2008, 8:97-120.
7. Scheiflinger F., Dorner F., Falkner F.G. Construction of chimeric vaccinia viruses by molecular cloning and packaging. Proc. Natl. Acad. Sci. USA 1992, 89:9977-9981.
8. Smith G.L., Mackett M., Moss B. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 1983, 302:490-495.
9. Staib C., Lowel M., Erfle V., Sutter G. Improved host range selection for recombinant modified vaccinia virus Ankara. Biotechniques 2003, 34. 694-696, 698, 700.
10. Tischer B.K., Kaufer B.B., Sommer M., Wussow F., Arvin A.M., Osterrieder N. A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9. J. Virol. 2007, 81:13200-13208.
11. Tischer B.K., von Einem J., Kaufer B., Osterrieder N. Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques 2006, 40:191-197.
12. Wyatt L.S., Belyakov I.M., Earl P.L., Berzofsky J.A., Moss B. Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA. Virology 2008, 372:260-272.
13. Wyatt L.S., Earl P.L., Xiao W., Americo J.L., Cotter C.A., Vogt J., Moss B. Elucidating and minimizing the loss by recombinant vaccinia virus of human immunodeficiency virus gene expression resulting from spontaneous mutations and positive selection. J. Virol. 2009, 83:7176-7184.